It seems we can’t find what you’re looking for. Perhaps searching can help.
Nothing found
Latest Articles
-
Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases
September 21, 2023 Comments Off on Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal MetastasesSAN DIEGO–(BUSINESS WIRE)—- $BIOC #CSF–Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces the full enrollment of 40 subjects with breast or non-small cell lung cancer (NSCLC) who have [...] -
September 21, 2023 Comments Off on Monoceros Biosystems and SeekIn Join Forces to Pave the Way for Cutting-Edge AI-Powered Cancer Diagnostics
-
September 21, 2023 Comments Off on The Endpoints 11 2023 winners: Biotech’s most exciting startups
-
September 21, 2023 Comments Off on Exclusive: AstraZeneca signs off on a ‘carbon negative’ new biotech building for one of its latest buyouts
-
September 21, 2023 Comments Off on Societal CDMO lays off 26 employees, starts hiring freeze after strategy review
Popular Articles
-
I recently looked over a company presentation for a friend and noticed something that I see a lot from scientists: she was being too modest in stating her reputation and abilities. When I pointed it [...]
-
-
-
-